BIIB vs QVCC · P/E 21, rev $9.89B vs rev $9.00B
Biogen Inc (BIIB) versus QVCC (QVCC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
QVCC (QVCC) is a other company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported QVCC revenue for 2024-12-31 was $9.00B. Net income was -$1.02B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the BIIB and QVCC stock pages for the full models.
Not investment advice.